Sutro Biopharma's total assets for Q1 2025 were $321.43M, a decrease of -16.99% from the previous quarter. STRO total liabilities were $347.24M for the fiscal quarter, a 1.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.